The ability of UPP1-overexpressing tumor cells to resist T cell-mediated elimination, which can be partially reversed by PD-L1 blockade in vitro, further underscored the clinical relevance of the UPP1-PD-L1 axis. This evidence concerns the gene CD274 and neoplasm.